| Product NDC: | 50991-582 |
| Proprietary Name: | DECONEX |
| Non Proprietary Name: | Guaifenesin, Phenylephrine Hydrochloride |
| Active Ingredient(s): | 390; 10 mg/1; mg/1 & nbsp; Guaifenesin, Phenylephrine Hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 50991-582 |
| Labeler Name: | Poly Pharmaceuticals |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part341 |
| Marketing Category: | OTC MONOGRAPH FINAL |
| Start Marketing Date: | 20120207 |
| Package NDC: | 50991-582-60 |
| Package Description: | 60 CAPSULE in 1 BOTTLE (50991-582-60) |
| NDC Code | 50991-582-60 |
| Proprietary Name | DECONEX |
| Package Description | 60 CAPSULE in 1 BOTTLE (50991-582-60) |
| Product NDC | 50991-582 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Guaifenesin, Phenylephrine Hydrochloride |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20120207 |
| Marketing Category Name | OTC MONOGRAPH FINAL |
| Labeler Name | Poly Pharmaceuticals |
| Substance Name | GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE |
| Strength Number | 390; 10 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes |